Technical Analysis for ENZ - Enzo Biochem, Inc.

Grade Last Price % Change Price Change
C 3.34 -3.47% -0.12
ENZ closed down 3.47 percent on Monday, April 12, 2021, on 20 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical ENZ trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Fell Below 20 DMA Bearish -3.47%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.47%
Narrow Range Bar Range Contraction -3.47%
Wide Bands Range Expansion -3.47%
20 DMA Support Bullish -4.02%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -4.02%
Narrow Range Bar Range Contraction -4.02%
Wide Bands Range Expansion -4.02%
Narrow Range Bar Range Contraction -3.75%
Older End-of-Day Signals for ENZ ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 13 hours ago
60 Minute Opening Range Breakdown about 15 hours ago
Down 3% about 17 hours ago
Down 2 % about 17 hours ago
Down 1% about 17 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Enzo Biochem, Inc. Description

Enzo Biochem, Inc., an integrated life sciences and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Clinical Labs, Life Sciences, and Therapeutics. The Clinical Labs segment offers routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. This segment operates a full-service clinical laboratory, a network of approximately 30 patient service centers, a laboratory, and a full-service phlebotomy and in-house logistics department. The Life Sciences segment manufactures, develops, and markets products and tools to life sciences, drug development, and clinical research customers. It provides proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which offer tools for target identification/validation, high content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis to life science researchers. This segment provides its products to scientific experts primarily in the field of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Therapeutics segment researches and develops therapeutic drug candidates in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. The company sells its products through its direct sales force; and a network of distributors worldwide. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Cancer Life Sciences Biology Acid Diabetes Antibodies Gastrointestinal Autoimmune Disease Molecular Biology Injury Clinical Research Drug Development Ophthalmic Cardiovascular Disease Lab Testing Neurological Disorders Gene Expression Obesity Peptides Genetic Engineering Metabolic Disease Metabolic Diseases Urological Disorders Dyes Search Products Biochemistry Medical Laboratory Research Products Endocrine Disorders Medical Diagnosis Diagnostic And Research Products

Is ENZ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 4.85
52 Week Low 1.8
Average Volume 1,347,204
200-Day Moving Average 2.57
50-Day Moving Average 3.25
20-Day Moving Average 3.53
10-Day Moving Average 3.44
Average True Range 0.22
ADX 24.24
+DI 26.25
-DI 23.42
Chandelier Exit (Long, 3 ATRs ) 4.20
Chandelier Exit (Short, 3 ATRs ) 3.45
Upper Bollinger Band 4.02
Lower Bollinger Band 3.03
Percent B (%b) 0.31
BandWidth 28.07
MACD Line 0.07
MACD Signal Line 0.10
MACD Histogram -0.026
Fundamentals Value
Market Cap 163.58 Million
Num Shares 49 Million
EPS 0.03
Price-to-Earnings (P/E) Ratio 111.33
Price-to-Sales 1.24
Price-to-Book 1.62
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.58
Resistance 3 (R3) 3.58 3.51 3.54
Resistance 2 (R2) 3.51 3.45 3.51 3.53
Resistance 1 (R1) 3.42 3.41 3.39 3.42 3.51
Pivot Point 3.35 3.35 3.33 3.35 3.35
Support 1 (S1) 3.26 3.29 3.23 3.26 3.17
Support 2 (S2) 3.19 3.25 3.19 3.15
Support 3 (S3) 3.10 3.19 3.14
Support 4 (S4) 3.10